Literature DB >> 17245433

Metalloproteases regulate T-cell proliferation and effector function via LAG-3.

Nianyu Li1, Yao Wang, Karen Forbes, Kate M Vignali, Bret S Heale, Paul Saftig, Dieter Hartmann, Roy A Black, John J Rossi, Carl P Blobel, Peter J Dempsey, Creg J Workman, Dario A A Vignali.   

Abstract

Tight control of T-cell proliferation and effector function is essential to ensure an effective but appropriate immune response. Here, we reveal that this is controlled by the metalloprotease-mediated cleavage of LAG-3, a negative regulatory protein expressed by all activated T cells. We show that LAG-3 cleavage is mediated by two transmembrane metalloproteases, ADAM10 and ADAM17, with the activity of both modulated by two distinct T-cell receptor (TCR) signaling-dependent mechanisms. ADAM10 mediates constitutive LAG-3 cleavage but increases approximately 12-fold following T-cell activation, whereas LAG-3 shedding by ADAM17 is induced by TCR signaling in a PKCtheta-dependent manner. LAG-3 must be cleaved from the cell surface to allow for normal T-cell activation as noncleavable LAG-3 mutants prevented proliferation and cytokine production. Lastly, ADAM10 knockdown reduced wild-type but not LAG-3(-/-) T-cell proliferation. These data demonstrate that LAG-3 must be cleaved to allow efficient T-cell proliferation and cytokine production and establish a novel paradigm in which T-cell expansion and function are regulated by metalloprotease cleavage with LAG-3 as its sole molecular target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245433      PMCID: PMC1783452          DOI: 10.1038/sj.emboj.7601520

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

Review 1.  The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis.

Authors:  H F Bigg; A D Rowan
Journal:  Curr Opin Pharmacol       Date:  2001-06       Impact factor: 5.547

Review 2.  Intramembrane proteolysis controls diverse signalling pathways throughout evolution.

Authors:  Sinisa Urban; Matthew Freeman
Journal:  Curr Opin Genet Dev       Date:  2002-10       Impact factor: 5.578

Review 3.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Authors:  Andrew H Baker; Dylan R Edwards; Gillian Murphy
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

4.  Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.

Authors:  Creg J Workman; Kari J Dugger; Dario A A Vignali
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

5.  Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity.

Authors:  Douglas W Ethell; Ross Kinloch; Douglas R Green
Journal:  Curr Biol       Date:  2002-09-17       Impact factor: 10.834

Review 6.  Protein kinase C(theta) in T cell activation.

Authors:  Noah Isakov; Amnon Altman
Journal:  Annu Rev Immunol       Date:  2002       Impact factor: 28.527

7.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3).

Authors:  Creg J Workman; Dennis S Rice; Kari J Dugger; Cornelia Kurschner; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

9.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.

Authors:  Yibing Yan; Kyoko Shirakabe; Zena Werb
Journal:  J Cell Biol       Date:  2002-07-15       Impact factor: 10.539

View more
  85 in total

Review 1.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

2.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

Authors:  Paul E Zarek; Ching-Tai Huang; Eric R Lutz; Jeanne Kowalski; Maureen R Horton; Joel Linden; Charles G Drake; Jonathan D Powell
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

Review 3.  Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

Authors:  Stephanie Grebinoski; Dario Aa Vignali
Journal:  Curr Opin Immunol       Date:  2020-06-30       Impact factor: 7.486

4.  Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation.

Authors:  Takeo K Maeda; Daisuke Sugiura; Il-Mi Okazaki; Takumi Maruhashi; Taku Okazaki
Journal:  J Biol Chem       Date:  2019-02-13       Impact factor: 5.157

5.  Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.

Authors:  Viswa Teja Colluru; Christopher D Zahm; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

6.  LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes.

Authors:  Qianxia Zhang; Maria Chikina; Andrea L Szymczak-Workman; William Horne; Jay K Kolls; Kate M Vignali; Daniel Normolle; Maria Bettini; Creg J Workman; Dario A A Vignali
Journal:  Sci Immunol       Date:  2017-03-31

7.  Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.

Authors:  Anne Fröhlich; Judith Sirokay; Simon Fietz; Timo J Vogt; Jörn Dietrich; Romina Zarbl; Mike Florin; Pia Kuster; Gonzalo Saavedra; Susana Ramírez Valladolid; Friederike Hoffmann; Lukas Flatz; Sandra S Ring; Carsten Golletz; Torsten Pietsch; Sebastian Strieth; Peter Brossart; Gerrit H Gielen; Glen Kristiansen; Friedrich Bootz; Jennifer Landsberg; Dimo Dietrich
Journal:  EBioMedicine       Date:  2020-08-30       Impact factor: 8.143

8.  Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral Nutrition.

Authors:  Yongjia Feng; Yu-Hwai Tsai; Weidong Xiao; Matthew W Ralls; Alex Stoeck; Carole L Wilson; Elaine W Raines; Daniel H Teitelbaum; Peter J Dempsey
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

9.  ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progression.

Authors:  David M Gravano; Bryce T McLelland; Keisuke Horiuchi; Jennifer O Manilay
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

10.  LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.

Authors:  Kevin D Cook; Jason K Whitmire
Journal:  J Immunol       Date:  2016-05-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.